XRP Healthcare has taken a significant step forward in its mission to enhance healthcare access across Africa through the acquisition of Pharma Ville, a leading pharmacy chain in Uganda. This expansion strengthens our footprint in the region and reinforces our commitment to delivering high-quality medical solutions to communities in need.
To support this growth, we’ve forged strategic alliances with a network of globally recognized healthcare providers and pharmaceutical companies. While many of these collaborations have been announced previously, we’re highlighting them again to provide a consolidated reference for our community and stakeholders.
Driving Healthcare Innovation Through Global Partnerships
Our partnerships are integral to ensuring Uganda—and ultimately, broader regions of Africa—receive essential, affordable, and high-quality medical supplies. Each collaborator brings specialized expertise, contributing to our vision of revolutionizing private healthcare across the continent.
We are proud to partner with:
-
Incepta Pharmaceuticals – A leading Bangladeshi pharmaceutical firm known for its expertise in generics and vaccines.
-
Ascensia Diabetes Care – A global innovator in diabetes management, renowned for its CONTOUR® glucose monitoring solutions.
-
Universal Corporation – A key player in the global leaf tobacco industry.
-
Naari – A specialist in pharmaceuticals dedicated to women’s health.
-
Amanta Healthcare – A manufacturer specializing in sterile injectables and IV infusions.
-
Marie Stopes Uganda – A trusted provider of reproductive health and family planning services.
-
Medrull – Recognized for its advancements in wound care and first-aid products.
-
Toros Group – A reliable distributor of pharmaceuticals and medical supplies.
Shaping the Future of Healthcare in Africa
With the acquisition of Pharma Ville and these strategic partnerships, XRP Healthcare is positioned to make a lasting impact on Uganda’s healthcare system. Our long-term vision is clear: to strengthen supply chains, improve access to life-saving treatments, and unlock Africa’s $259 billion healthcare potential.
This is just the beginning—together with our partners, we are building a healthier, more accessible future for Africa.
